Pure Global
NCT05353478

Reducing Opioid Prescription After Kidney Stone Removal Surgery

Reducing Opioids After Percutaneous Stone Surgery
Mayo Clinic·ClinicalTrials.govRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Kidney Stone
Study type
Observational
Sponsor & location
Primary sponsor
Mayo Clinic
Location
Rochester, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jun 06, 2022
End date
Jun 01, 2023
Enrollment
100 participants
Primary outcome

Unused opioid prescriptions

Summary

The purpose of this study is to implement and assess a standard way of prescribing opioid
 pain medication following PCNL (a kidney stone removal surgery) to ensure patients are being
 discharged with an appropriate quantity of pain management medication.

ICD-10 classifications
Kidney dialysisSmall kidney, unspecifiedDisorder of kidney and ureter, unspecifiedInjury of kidneyUnspecified kidney failure
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05353478
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05353478 through Pure Global AI's free database. This phase not specified trial is sponsored by Mayo Clinic and is currently Recruiting. The study focuses on Kidney Stone. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.